Delivery Order SPE2DE21D0007-SPE2D624F2NUC

Award Date 9/19/24
Potential Completion Date 9/24/24
Potential Value $1.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DE21D0007
    Indefinite Delivery Contract
  • SPE2DE21D0007-SPE2D624F2NUC
    Delivery Order

This federal contract award with the ID SPE2DE21D0007|SPE2D624F2NUC was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc. for the delivery of 4565883575 ANTI-B BIOCLONE 15X10ML. The $1,832.54 fixed-price with economic price adjustment contract has an ultimate completion date of September 24, 2024. Ortho-Clinical Diagnostics is a medical equipment manufacturer that provides diagnostic solutions to various federal agencies, including the Department of Veterans Affairs, Defense Health Agency, and Department of Health and Human Services. This order does not have a set-aside designation. Ortho-Clinical Diagnostics holds several indefinite-delivery contracts with federal healthcare programs, including a $249,000 blanket purchase agreement to supply an immunohematology analyzer system and reagents to the Veterans Integrated Service Network 10, and a $32,921.85 five-year contract to provide blood bank reagents to the Veterans Health Administration's Veterans Integrated Service Network 17.

Generated 12/19/24, 9:11 AM